(Total Views: 638)
Posted On: 11/26/2018 4:56:54 PM
Post# of 72447
I didn’t know either and found it very encouraging. It’s good Kelt posted it as well to make more people aware of it if they happened to miss it.
After reading the description of the EOP2 meeting on the FDA website I came to understand - and believe! - two things:
1) The FDA already has all of the information to be discussed at the meeting
2) The meeting wouldn’t have been scheduled if there was going to be a problem.
It looks like the meeting is done to iron out the trial details and for the FDA to wiegh in on HOW to proceed, not IF.
I realize anything can happen, but it’s looking good.
After reading the description of the EOP2 meeting on the FDA website I came to understand - and believe! - two things:
1) The FDA already has all of the information to be discussed at the meeting
2) The meeting wouldn’t have been scheduled if there was going to be a problem.
It looks like the meeting is done to iron out the trial details and for the FDA to wiegh in on HOW to proceed, not IF.
I realize anything can happen, but it’s looking good.
(2)
(0)
